5. Stresses that data collection, analysis and evaluation of the results of ongoing national and international policies are essential tools for further developing sound, evidence-based drug control strategies, and therefore encourages Member States to further develop and institutionalize monitoring and evaluation tools and to utilize existing available data to exchange and share information at all levels;
5. 强调数据收集和分析以及对现行国家和国际政策的结果进行评估是进一步制定完善的循证药物管制战略的必要手段，因此鼓励会员国进一步发展监测和评价工具并使之体制化，并利用现有信息在各级交换和交流信息；